logo
Plus   Neg
Share
Email

Stock Alert: Haemonetics Corporation Down 8%

Shares of healthcare company, providing hematology products and solutions, Haemonetics Corporation (HAE) are down more than 8% Tuesday morning at $80.01. It has traded in the range of $63.41- $140.36 in the past one year.

The company said the pandemic has significantly impacted its first-quarter financial results.

The company reported first-quarter adjusted EPS of $0.46 per share, down 43.2% from last year, but beat the average estimate of analysts polled by Thomson Reuters at $0.41 per share.

Revenue for the quarter decreased 18% to $196 million. The consensus estimate was at $198.27 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
RELATED NEWS
Follow RTT